Abstract
Adoptive transfer of antigen-specific, in vitro-induced Foxp3+ Treg (iTreg) cells protects against autoimmune disease. To generate antigen-specific iTreg cells at high purity, however, remains a challenge. Whereas polyclonal T cell stimulation with anti-CD3 and anti-CD28 antibody yields Foxp3+ iTreg cells at a purity of 90-95%, antigen-induced iTreg cells typically do not exceed a purity of 65-75%, even in a TCR-transgenic model. In a similar vein to thymic Treg cell selection, iTreg cell differentiation is influenced not only by antigen recognition and the availability of TGF-β but also by co-factors including costimulation and adhesion molecules. In this study, we demonstrate that blockade of the T cell integrin Leukocyte Function-associated Antigen-1 (LFA-1) during antigen-mediated iTreg cell differentiation augments Foxp3 induction, leading to approximately 90% purity of Foxp3+ iTreg cells. This increased efficacy not only boosts the yield of Foxp3+ iTreg cells, it also reduces contamination with activated effector T cells, thus improving the safety of adoptive transfer immunotherapy.
Original language | English |
---|---|
Pages (from-to) | 58-64 |
Number of pages | 7 |
Journal | Journal of Immunological Methods |
Volume | 414 |
Early online date | 6 Aug 2014 |
DOIs | |
Publication status | Published - 1 Dec 2014 |
Keywords
- Adoptive Transfer
- Animals
- Autoimmune Diseases
- Autoimmunity
- CTLA-4 Antigen
- Cell Differentiation
- Cells, Cultured
- Forkhead Transcription Factors
- Interleukin-2
- Lymphocyte Function-Associated Antigen-1
- Mice
- Mice, Transgenic
- Signal Transduction
- T-Lymphocytes, Regulatory
- Transforming Growth Factor beta
- Journal Article
- Research Support, Non-U.S. Gov't
- Foxp3
- LFA-1
- Treg cell
- Immunotherapy